Merck & Company Inc (MRK)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 4,538,000 -2,574,000 -633,000 -11,926,000 -13,809,000 -8,463,000 -10,244,000 -41,000 1,965,000 3,890,000 4,765,000 1,828,000 -1,314,000 -10,863,000 -12,556,000 -11,169,000 -9,969,000 -1,971,000 -4,146,000 -4,282,000
Total assets US$ in thousands 117,106,000 117,532,000 112,630,000 105,849,000 106,675,000 106,727,000 104,469,000 107,796,000 109,160,000 107,081,000 107,095,000 106,668,000 105,694,000 93,494,000 90,688,000 90,847,000 91,588,000 89,800,000 90,615,000 84,913,000
Operating ROA 3.88% -2.19% -0.56% -11.27% -12.94% -7.93% -9.81% -0.04% 1.80% 3.63% 4.45% 1.71% -1.24% -11.62% -13.85% -12.29% -10.88% -2.19% -4.58% -5.04%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $4,538,000K ÷ $117,106,000K
= 3.88%

Operating Return on Assets (Operating ROA) is a key financial ratio that indicates how efficiently a company generates profits from its assets utilized in its operations. Looking at the historical trend for Merck & Company Inc:

- From March 2020 to December 2021, the operating ROA showed a consistently negative trend, reaching its lowest point in June 2021 at -13.85%. This indicates that during this period, the company was not effectively utilizing its assets to generate operating profits.

- Starting from March 2022, there was a notable improvement in the operating ROA, turning positive and reaching its peak at 4.45% in June 2022. This could signify better operational efficiency and enhanced profitability from the assets.

- However, the operating ROA experienced fluctuations in the subsequent quarters, with some periods showing negative returns, particularly in December 2023 and March 2024.

- By December 2024, the operating ROA rebounded to a positive 3.88%, suggesting a potential resurgence in the company's ability to generate operating income from its assets.

Overall, the analysis of Merck & Company Inc's operating ROA indicates a mix of challenges and improvements in effectively utilizing its assets to drive operational profits over the reviewed period.